Shots: STADA acquires Lobsar and its innovative therapy to foster its footprints in specialty pharmaceuticals. The acquisition complements STADA’s portfolio and expertise in the treatment of late-stage Parkinson’s disease With […]readmore
Tags : Strengthen
Pregnancy is one of the most exciting and happy experiences in a woman’s life. Taking care of the mother and baby is essential throughout the pregnancy. During this period, the […]readmore
Shots: Amgen has consummated the purchase of Astellas’49% shares of AABP, a JV between Amgen and Astellas established in 2013 AABP now serves as a wholly-owned Amgen affiliate in Japan […]readmore
Shots: Cipla acquires Venus’ anti-infective products, Elores to robust its presence in Indian critical care space as a part of its agenda to contribute to the fight against Anti-Microbial Resistance […]readmore
Shots: CoolTone device penetrates the muscle layers and induces involuntary muscle contractions utilizing magnetic muscle stimulation, thus strengthening muscle fibers resulting in improved muscle conditioning CoolTone is considered to have […]readmore
Shots: AZ gains complete rights to monalizumab (Anti-NKG2A), also gains option rights to IPH5201 as well as 4 preclinical immuno-oncology molecules Innate gains US and EU rights of Lumoxiti approved […]readmore
Shots: Vector’s acquisition is an all-stock transaction including its novel P-II drug candidate AAV-GAD evaluated for Parkinson’s Disease The acquisition focuses on developing candidate AAV-GAD and providing novel treatments for […]readmore
Shots: Hologic to acquire Focal for its BioZorb marker, an implantable 3D marker helping surgeons to overcome challenges in breast conserving surgery, or lumpectomy used to mark tumor excision site […]readmore
Shots: ACEA to receive $250M in upfront cash as a total deal value, adding a differentiated portfolio and organizational capabilities in cell analysis Agilent will get hold of ACEA’s CFDA […]readmore